Ischaemic Conditioning and Targeting Reperfusion Injury: a 30 year Voyage of Discovery

To commemorate the auspicious occasion of the 30th anniversary of IPC, leading pioneers in the field of cardioprotection gathered in Barcelona in May 2016 to review and discuss the history of IPC, its evolution to IPost and RIC, myocardial reperfusion injury as a therapeutic target, and future targets and strategies for cardioprotection. This article provides an overview of the major topics discussed at this special meeting and underscores the huge importance and impact, the discovery of IPC has made in the field of cardiovascular research.

Citing Articles

IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT): a small animal acute myocardial infarction randomized-controlled multicenter study on the effect of ischemic preconditioning.

Hernandez-Resendiz S, Vilskersts R, Aluja D, Andreadou I, Bencsik P, Dambrova M Basic Res Cardiol. 2025; .

PMID: 40072549 DOI: 10.1007/s00395-025-01102-3.

Reperfused Myocardial Infarction: The Road to CCS Classification of Acute MI and Beyond.

Dharmakumar R, Kloner R, Fishbein M, Heusch G, Vora K, Gropler R JACC Adv. 2025; 4(2):101528.

PMID: 40021272 PMC: 11905164. DOI: 10.1016/j.jacadv.2024.101528.

A long-lived pool of PINK1 imparts a molecular memory of depolarization-induced activity.

Pollock L, Georgiou I, Rusilowicz-Jones E, Clague M, Urbe S Sci Adv. 2025; 11(9):eadr1938.

PMID: 40020067 PMC: 11870087. DOI: 10.1126/sciadv.adr1938.

Novel Selective Cardiac Myosin-Targeted Inhibitors Alleviate Myocardial Ischaemia-Reperfusion Injury.

Yusof N, Yellon D, Davidson S Cardiovasc Drugs Ther. 2025; .

PMID: 39754660 DOI: 10.1007/s10557-024-07663-0.

Antioxidative and cardioprotective effects of minocycline in ischemia/reperfusion injury in experimental model of hypertension.

Rudic T, Stojanovic A, Sobot N, Novakovic J, Bolevich S, Bolevich S Mol Cell Biochem. 2024; 480(3):1747-1762.

PMID: 39187740 DOI: 10.1007/s11010-024-05095-w.

References

Ruiz-Meana M, Garcia-Dorado D, Hofstaetter B, Piper H, Soler-Soler J . Propagation of cardiomyocyte hypercontracture by passage of Na(+) through gap junctions. Circ Res. 1999; 85(3):280-7. DOI: 10.1161/01.res.85.3.280. View

Noda T, Minatoguchi S, Fujii K, Hori M, Ito T, Kanmatsuse K . Evidence for the delayed effect in human ischemic preconditioning: prospective multicenter study for preconditioning in acute myocardial infarction. J Am Coll Cardiol. 1999; 34(7):1966-74. DOI: 10.1016/s0735-1097(99)00462-3. View

Gunaydin B, Cakici I, Soncul H, Kalaycioglu S, Cevik C, Sancak B . Does remote organ ischaemia trigger cardiac preconditioning during coronary artery surgery?. Pharmacol Res. 2000; 41(4):493-6. DOI: 10.1006/phrs.1999.0611. View

Pain T, Yang X, Critz S, Yue Y, Nakano A, Liu G . Opening of mitochondrial K(ATP) channels triggers the preconditioned state by generating free radicals. Circ Res. 2000; 87(6):460-6. DOI: 10.1161/01.res.87.6.460. View

Bilinska M, RUDNICKI S, Beresewicz A . Delayed attenuation of myocardial ischemia with repeated exercise in subjects with stable angina: a possible model for the second window of protection?. Basic Res Cardiol. 2000; 95(5):418-23. DOI: 10.1007/s003950070042. View

Varadarajan S, An J, Novalija E, Smart S, Stowe D . Changes in [Na(+)](i), compartmental [Ca(2+)], and NADH with dysfunction after global ischemia in intact hearts. Am J Physiol Heart Circ Physiol. 2000; 280(1):H280-93. DOI: 10.1152/ajpheart.2001.280.1.H280. View

Xu M, Wang Y, Hirai K, Ayub A, Ashraf M . Calcium preconditioning inhibits mitochondrial permeability transition and apoptosis. Am J Physiol Heart Circ Physiol. 2001; 280(2):H899-908. DOI: 10.1152/ajpheart.2001.280.2.H899. View

Heusch G . Nitroglycerin and delayed preconditioning in humans: yet another new mechanism for an old drug?. Circulation. 2001; 103(24):2876-8. DOI: 10.1161/01.cir.103.24.2876. View

Cohen M, Yang X, Liu G, Heusch G, Downey J . Acetylcholine, bradykinin, opioids, and phenylephrine, but not adenosine, trigger preconditioning by generating free radicals and opening mitochondrial K(ATP) channels. Circ Res. 2001; 89(3):273-8. DOI: 10.1161/hh1501.094266. View

10.

Lecour S, Smith R, Woodward B, Opie L, Rochette L, Sack M . Identification of a novel role for sphingolipid signaling in TNF alpha and ischemic preconditioning mediated cardioprotection. J Mol Cell Cardiol. 2002; 34(5):509-18. DOI: 10.1006/jmcc.2002.1533. View

11.

Hausenloy D, Maddock H, Baxter G, Yellon D . Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning?. Cardiovasc Res. 2002; 55(3):534-43. DOI: 10.1016/s0008-6363(02)00455-8. View

12.

Weinbrenner C, Nelles M, Herzog N, Sarvary L, Strasser R . Remote preconditioning by infrarenal occlusion of the aorta protects the heart from infarction: a newly identified non-neuronal but PKC-dependent pathway. Cardiovasc Res. 2002; 55(3):590-601. DOI: 10.1016/s0008-6363(02)00446-7. View

13.

Mirabet M, Garcia-Dorado D, Inserte J, Barrabes J, Soriano B, Azevedo M . Platelets activated by transient coronary occlusion exacerbate ischemia-reperfusion injury in rat hearts. Am J Physiol Heart Circ Physiol. 2002; 283(3):H1134-41. DOI: 10.1152/ajpheart.00065.2002. View

14.

Schulman D, Latchman D, Yellon D . Urocortin protects the heart from reperfusion injury via upregulation of p42/p44 MAPK signaling pathway. Am J Physiol Heart Circ Physiol. 2002; 283(4):H1481-8. DOI: 10.1152/ajpheart.01089.2001. View

15.

Ferdinandy P . Myocardial ischaemia/reperfusion injury and preconditioning: effects of hypercholesterolaemia/hyperlipidaemia. Br J Pharmacol. 2003; 138(2):283-5. PMC: 1573675. DOI: 10.1038/sj.bjp.0705097. View

16.

Yaguchi Y, Satoh H, Wakahara N, Katoh H, Uehara A, Terada H . Protective effects of hydrogen peroxide against ischemia/reperfusion injury in perfused rat hearts. Circ J. 2003; 67(3):253-8. DOI: 10.1253/circj.67.253. View

17.

Lambiase P, Edwards R, Cusack M, Bucknall C, Redwood S, Marber M . Exercise-induced ischemia initiates the second window of protection in humans independent of collateral recruitment. J Am Coll Cardiol. 2003; 41(7):1174-82. DOI: 10.1016/s0735-1097(03)00055-x. View

18.

Zhao Z, Corvera J, Halkos M, Kerendi F, Wang N, Guyton R . Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol. 2003; 285(2):H579-88. DOI: 10.1152/ajpheart.01064.2002. View

19.

Padilla F, Garcia-Dorado D, Rodriguez-Sinovas A, Ruiz-Meana M, Inserte J, Soler-Soler J . Protection afforded by ischemic preconditioning is not mediated by effects on cell-to-cell electrical coupling during myocardial ischemia-reperfusion. Am J Physiol Heart Circ Physiol. 2003; 285(5):H1909-16. DOI: 10.1152/ajpheart.00438.2003. View

20.

Auchampach J, Grover G, Gross G . Blockade of ischaemic preconditioning in dogs by the novel ATP dependent potassium channel antagonist sodium 5-hydroxydecanoate. Cardiovasc Res. 1992; 26(11):1054-62. DOI: 10.1093/cvr/26.11.1054. View